» Articles » PMID: 14999097

Hepatitis C Virus Induces a Mutator Phenotype: Enhanced Mutations of Immunoglobulin and Protooncogenes

Overview
Specialty Science
Date 2004 Mar 5
PMID 14999097
Citations 145
Authors
Affiliations
Soon will be listed here.
Abstract

Hepatitis C virus (HCV) is a nonretroviral oncogenic RNA virus, which is frequently associated with hepatocellular carcinoma (HCC) and B cell lymphoma. We demonstrated here that acute and chronic HCV infection caused a 5- to 10-fold increase in mutation frequency in Ig heavy chain, BCL-6, p53, and beta-catenin genes of in vitro HCV-infected B cell lines and HCV-associated peripheral blood mononuclear cells, lymphomas, and HCCs. The nucleotide-substitution pattern of p53 and beta-catenin was different from that of Ig heavy chain in HCV-infected cells, suggesting two different mechanisms of mutation. In addition, the mutated protooncogenes were amplified in HCV-associated lymphomas and HCCs, but not in lymphomas of nonviral origin or HBV-associated HCC. HCV induced error-prone DNA polymerase zeta, polymerase iota, and activation-induced cytidine deaminase, which together, contributed to the enhancement of mutation frequency, as demonstrated by the RNA interference experiments. These results indicate that HCV induces a mutator phenotype and may transform cells by a hit-and-run mechanism. This finding provides a mechanism of oncogenesis for an RNA virus.

Citing Articles

B Cell Differentiation and the Origin and Pathogenesis of Human B Cell Lymphomas.

Weniger M, Seifert M, Kuppers R Methods Mol Biol. 2024; 2865:1-30.

PMID: 39424718 DOI: 10.1007/978-1-0716-4188-0_1.


Extrahepatic Cancer Risk in Patients with Hepatitis C Virus Infection Treated with Direct-Acting Antivirals.

Tani J, Masaki T, Oura K, Tadokoro T, Morishita A, Kobara H Microorganisms. 2024; 12(9).

PMID: 39338599 PMC: 11434491. DOI: 10.3390/microorganisms12091926.


Leveraging oncovirus-derived antigen against the viral malignancies in adoptive cell therapies.

Zhang W, Zeng M, Li Y, Yu L Biomark Res. 2024; 12(1):71.

PMID: 39075601 PMC: 11287861. DOI: 10.1186/s40364-024-00617-6.


Carcinogenic mechanisms of virus-associated lymphoma.

Zhang Y, Guo W, Zhan Z, Bai O Front Immunol. 2024; 15:1361009.

PMID: 38482011 PMC: 10932979. DOI: 10.3389/fimmu.2024.1361009.


SARS-CoV-2 and the DNA damage response.

Grand R J Gen Virol. 2023; 104(11).

PMID: 37948194 PMC: 10768691. DOI: 10.1099/jgv.0.001918.


References
1.
Strathern J, Shafer B, McGill C . DNA synthesis errors associated with double-strand-break repair. Genetics. 1995; 140(3):965-72. PMC: 1206680. DOI: 10.1093/genetics/140.3.965. View

2.
Ferri C, Caracciolo F, Zignego A, La Civita L, Monti M, Longombardo G . Hepatitis C virus infection in patients with non-Hodgkin's lymphoma. Br J Haematol. 1994; 88(2):392-4. DOI: 10.1111/j.1365-2141.1994.tb05036.x. View

3.
Migliazza A, Martinotti S, Chen W, Fusco C, Ye B, Knowles D . Frequent somatic hypermutation of the 5' noncoding region of the BCL6 gene in B-cell lymphoma. Proc Natl Acad Sci U S A. 1995; 92(26):12520-4. PMC: 40389. DOI: 10.1073/pnas.92.26.12520. View

4.
Silvestri F, Pipan C, Barillari G, Zaja F, Fanin R, Infanti L . Prevalence of hepatitis C virus infection in patients with lymphoproliferative disorders. Blood. 1996; 87(10):4296-301. View

5.
Dorner T, Brezinschek H, Brezinschek R, Foster S, Domiati-Saad R, Lipsky P . Analysis of the frequency and pattern of somatic mutations within nonproductively rearranged human variable heavy chain genes. J Immunol. 1997; 158(6):2779-89. View